

[ Mon, Jul 01st 2024
] - WOPRAI


[ Wed, Dec 13th 2023
] - WOPRAI


[ Mon, Jul 11th 2022
] - WOPRAI


[ Thu, Jul 01st 2021
] - WOPRAI

[ Wed, Apr 21st 2021
] - WOPRAI


[ Wed, Mar 24th 2021
] - WOPRAI

[ Mon, Mar 15th 2021
] - WOPRAI

[ Mon, Jan 25th 2021
] - WOPRAI

[ Wed, Dec 16th 2020
] - WOPRAI

[ Tue, Dec 01st 2020
] - WOPRAI

[ Wed, Nov 11th 2020
] - WOPRAI

[ Fri, Oct 09th 2020
] - WOPRAI

[ Tue, Oct 06th 2020
] - WOPRAI
[ Tue, Oct 06th 2020
] - WOPRAI

[ Thu, Sep 03rd 2020
] - WOPRAI

[ Tue, Jul 07th 2020
] - WOPRAI

[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI

[ Tue, Mar 24th 2020
] - WOPRAI

[ Mon, Apr 22nd 2019
] - WOPRAI


[ Tue, Dec 11th 2018
] - WOPRAI
[ Tue, Dec 11th 2018
] - WOPRAI

James Picariello Upgraded (ADNT) to Hold and Held Target at $26 on, Jul 1st, 2024
James Picariello of Exane BNP Paribas, Upgraded "Adient plc" (ADNT) to Hold and Held Target at $26 on, Jul 1st, 2024.
James has made no other calls on ADNT in the last 4 months.
There are 7 other peers that have a rating on ADNT. Out of the 7 peers that are also analyzing ADNT, 4 agree with James's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ryan Brinkman of "JP Morgan" Maintained at Hold with Decreased Target to $32 on, Tuesday, May 7th, 2024
- Dan Levy of "Barclays" Maintained at Hold with Decreased Target to $34 on, Tuesday, May 7th, 2024
- Emmanuel Rosner of "Deutsche Bank" Maintained at Hold with Decreased Target to $30 on, Monday, May 6th, 2024
- Joseph Spak of "UBS" Maintained at Hold with Decreased Target to $31 on, Monday, May 6th, 2024
These are the ratings of the 3 analyists that currently disagree with James
- Colin Langan of "Wells Fargo" Maintained at Buy with Decreased Target to $32 on, Tuesday, June 25th, 2024
- Adam Jonas of "Morgan Stanley" Maintained at Sell with Decreased Target to $32 on, Friday, May 10th, 2024
- John Murphy of "B of A Securities" Maintained at Strong Buy with Decreased Target to $46 on, Wednesday, April 10th, 2024